XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 102 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q1 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $558,000 | -5.3% | 300,000 | +33.3% | 0.14% | -21.2% |
| Q2 2023 | $589,500 | -9.6% | 225,000 | -43.8% | 0.18% | -29.2% |
| Q1 2023 | $652,000 | +122456.4% | 400,000 | 0.0% | 0.25% | +42.9% |
| Q4 2022 | $532 | -99.9% | 400,000 | 0.0% | 0.18% | +21.2% |
| Q3 2022 | $624,000 | +15.8% | 400,000 | +14.3% | 0.15% | +7.4% |
| Q2 2022 | $539,000 | -66.7% | 350,000 | -44.7% | 0.14% | -32.3% |
| Q1 2022 | $1,620,000 | +87.5% | 633,040 | +114.6% | 0.20% | +58.3% |
| Q4 2021 | $864,000 | – | 295,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,039,028 | $15,460,000 | 19.22% |
| Stonepine Capital Management, LLC | 7,924,056 | $20,286,000 | 8.41% |
| ARMISTICE CAPITAL, LLC | 7,464,993 | $19,110,000 | 0.37% |
| NEA Management Company, LLC | 3,246,785 | $8,312,000 | 0.24% |
| Alpine Global Management, LLC | 633,040 | $1,620,000 | 0.20% |
| DELTEC ASSET MANAGEMENT LLC | 248,000 | $635,000 | 0.11% |
| Redmile Group, LLC | 1,046,587 | $2,679,000 | 0.08% |
| CTC Capital Management, LLC | 11,800 | $30,000 | 0.08% |
| TUDOR INVESTMENT CORP ET AL | 961,192 | $2,461,000 | 0.06% |
| Yakira Capital Management, Inc. | 117,076 | $300,000 | 0.04% |